FDA Oncology Center of Excellence Listening Session with NORD: A Patient Perspective
Written by Laura Mullen on June 24, 2020
A Note from NORD:
In May, NORD was approached by the Oncology Center of Excellence (OCE) at the US Food and Drug Administration (FDA) to collaborate on a new initiative to help enhance communication revolving around the conduct of clinical trials for rare cancer drug development during… Read More